Residual red blood cells in liquid plasma products: A quality assessment
The findings confirm that LP prepared under current blood processing standards contains no detectable residual RBCs, supporting its safety for transfusion with ABO-compatible products without the need for consideration of RhD compatibility.
Authors
- Furkan Yiğitbilek (ORCID: https://orcid.org/0000-0003-1736-994X)
- Tho D. Pham (ORCID: https://orcid.org/0000-0002-5900-0289)
- Mrigender Virk (ORCID: https://orcid.org/0000-0003-3232-2090)
- Suchitra Pandey (ORCID: https://orcid.org/0000-0003-3614-2353)
Institutions
- Stanford University (US)
Publication Details
- Journal
- American Journal of Clinical Pathology
- Published
- 2025-03-29
- DOI
- https://doi.org/10.1093/ajcp/aqaf036
- Primary Topic
- Blood transfusion and management
- Type
- article
- Field-Weighted Citation Impact
- 0.00